Myeongmun Pharmaceutical rises 7.88% amid deworming drug (Fenbendazole, etc.) theme uptrend

On the 5th, the theme of anthelmintics (including fenbendazole) showed strength by rising 3.43% compared to the previous day, while Myungmoon Pharmaceutical, which is attracting attention as a related stock, surged 7.88% compared to the previous day. Myungmoon Pharmaceutical is known as a comprehensive pharmaceutical company focusing on prescription drugs.

[Graph] Price Fluctuations of Major Stocks in the Anthelmintics (Including Fenbendazole) Theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Myungmoon Pharmaceutical's quant financial score is 7.3 points, which is lower in stability, profitability, and growth compared to the average of other stocks related to anthelmintics (including fenbendazole). This can be interpreted as Myungmoon Pharmaceutical having relatively low investment attractiveness compared to other stocks from a financial perspective. On the other hand, Allico Pharmaceutical ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top Stocks by Financial Score within the Theme

※ The quant financial score is the result of the robo algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.